For ovarian cancer, the cumulative risk in carriers of BRCA1 PV is low under the age of 45 years but reaches more than 10% by the age of 55 years, whereas it remains low until the age of 65 years for BRCA2 mutation carriers. This evidence concerns the gene BRCA1 and ovarian cancer.